ADVERSE REACTIONS ——— ——— DOSAGE FORMS AND …
• Injection: 6 mg/mL solution in a 3 mL pre-filled, single-patient-use pen that delivers doses of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg or 3 mg (3). ——— CONTRAINDICATIONS ——— • Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 …
Download ADVERSE REACTIONS ——— ——— DOSAGE FORMS AND …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Malfunction: NOVOLOG - novo-pi.com
www.novo-pi.comNovoLog® (insulin aspart injection) 2 5.7 Fluid Retention and Heart Failure with Concomitant Use of PPAR-gamma Agonists Thiazolidinediones (TZDs), …
MEDICATION GUIDE What is the most important …
www.novo-pi.comMEDICATION GUIDE Saxenda (sax-end-ah) (liraglutide) injection solution for subcutaneous use What is the most important information I should know about Saxenda?
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
www.novo-pi.comVICTOZA ® 2 FULL PRESCRIBING INFORMATION WARNING: RISK OF THYROID C−CELL TUMORS • Liraglutide causes dose-dependent and …
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
www.novo-pi.comozempic ® ® ® ® ® ®-® ozempic ® ® ® ® ozempic® ® ® ® ®®) ®
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.novo-pi.comTRESIBA ® 2. 2 2. ® ® 2 2 and 2. ® ® ® 2 ® ® TRESIBA® Hypoglycemia ® ® ® § ® ® ® ® ® Novo Nordisk hypoglycemia § TRESIBA® ® TRESIBA ® TRESIBA ® TRESIBA TRESIBA
DOSAGE AND ADMINISTRATION - novo-pi.com
www.novo-pi.comNovoSeven® ® ® ® ® ≥ ® ® ® 2 NovoSeven ® ® RT, ®. ® ® ®® ® RT ® ® RT. ® ® ® 3 ® ® ® ® NovoSeven®® RT ® RT. ® NovoSeven ® ® ® NovoSeven® ® ®®®®, ® ® ® RT ® ® ®
HIGHLIGHTS OF PRESCRIBING INFORMATION - …
www.novo-pi.com1 ——— INDICATIONS AND USAGE ——— Saxenda® is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced-calorie diet and increased
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
www.novo-pi.comOZEMPIC ® semaglutide) injection, for sucutaneous use 2 FULL PRESCRIBING INFORMATION WARNING: RISK OF THYROID C−CELL TUMORS • persistent hoarseness).In rodents, semaglutide causes dose-dependent and treatment-duration-
HIGHLIGHTS OF PRESCRIBING INFORMATION - …
www.novo-pi.comLEVEMIR® (insulin detemir [rDNA origin] injection) 2 fluid retention, particularly when used in combination with insulin. Fluid retention may lead to or exacerbate heart failure. Patients
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.novo-pi.comTRESIBA ® (insulin degludec necton) 2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE TRESIBA® is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus. Limitations of Use • Not recommended for the treatment of diabetic ketoacidosis.